Collaboration Between Nursing and Pharmacy Teams in Managing Polypharmacy Among Older Adults
DOI:
https://doi.org/10.22399/ijcesen.4283Keywords:
Polypharmacy, older adults, nursing, pharmacy, collaboration, medication managementAbstract
Polypharmacy, defined as the concurrent use of multiple medications, poses significant risks for older adults, such as increased adverse drug reactions, drug interactions, and medication non-adherence. As the population ages, the prevalence of polypharmacy continues to rise, necessitating a strategic approach to medication management. Effective collaboration between nursing and pharmacy teams is crucial in addressing the complexities associated with polypharmacy in this vulnerable population. Nurses, who have the most frequent contact with patients, can provide valuable insights into medication adherence and the patient's overall health status. Meanwhile, pharmacists bring their expertise in pharmacology and medication management, making them essential partners in the interdisciplinary team. Together, they can conduct comprehensive medication reviews, assess each patient’s medication regimen for safety and efficacy, and implement deprescribing strategies when necessary. One of the key advantages of this collaboration is the enhancement of care quality through improved patient outcomes. By engaging in regular communication and information sharing, nursing and pharmacy teams can identify potential medication-related problems early and design tailored interventions. For instance, joint initiatives, such as medication reconciliation at hospital discharge or the implementation of polypharmacy clinics, can significantly reduce hospital readmissions and enhance patient safety. Furthermore, involving patients and their caregivers in discussions about their medications fosters shared decision-making, which can improve adherence and satisfaction. Ultimately, this interdisciplinary collaboration not only enriches the competency of healthcare providers but also significantly benefits the health and well-being of older adults managing polypharmacy.
References
1. Al Shemeili S., Klein S., Strath A., Fares S., Stewart D. An exploration of health professionals' experiences of medicines management in elderly, hospitalised patients in Abu Dhabi. International Journal of Clinical Pharmacy. 2016;38:107-118.
2. Anthierens S., Tansens A., Petrovic M., Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Family Practice. 2010;11:65.
3. Bell H.T., Granas A.G., Enmarker I., Omli R., Steinsbekk A. Nurses' and pharmacists' learning experiences from participating in interprofessional medication reviews for elderly in primary health care - A qualitative study. BMC Family Practice. 2017;18:30.
4. Chen C., Feng Z., Fu Q., Wang J., Zheng Z., Chen H., Feng D. Predictors of polypharmacy among elderly patients in China: The role of decision involvement, depression, and taking Chinese medicine behavior. Frontiers in Pharmacology. 2021;12:745688.
5. Choo J., Hutchinson A., Bucknall T. Nurses' role in medication safety. Journal of Nursing Management. 2010;18:853-861.
6. Costa M., Correard F., Montaleytang M., Baumstarck K., Loubière S., Amichi K., Villani P., Honore S., Daumas A., Verger P. Acceptability of a novel telemedication review for older adults in nursing homes in France: A qualitative study. Clinical Interventions in Aging. 2021;16:19-34.
7. Coster S., Watkins M., Norman I.J. What is the impact of professional nursing on patients' outcomes globally? An overview of research evidence. International Journal of Nursing Studies. 2018;78:76-83.
8. Critical Appraisal Skills Programme. CASP qualitative studies checklist. 2022.
9. Danielsen B.V., Sand A.M., Rosland J.H., Førland O. Experiences and challenges of home care nurses and general practitioners in home-based palliative care-a qualitative study. BMC Palliative Care. 2018;17:95.
10. Doyle L., McCabe C., Keogh B., Brady A., McCann M. An overview of the qualitative descriptive design within nursing research. Journal of Research in Nursing. 2020;25:443-455.
11. Dumbreck S., Flynn A., Nairn M., Wilson M., Treweek S., Mercer S.W., Alderson P., Thompson A., Payne K., Guthrie B. Drug-disease and drug-drug interactions: Systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015;350:h949.
12. Eriksen C.U., Kyriakidis S., Christensen L.D., Jacobsen R., Laursen J., Christensen M.B., Frølich A. Medication-related experiences of patients with polypharmacy: A systematic review of qualitative studies. BMJ Open. 2020;10:e036158.
13. Farrell B., Thompson W., Black C.D., Archibald D., Raman-Wilms L., Grassau P., Patel T., Weaver L., Eid K., Winslade N. Health care providers' roles and responsibilities in management of polypharmacy: Results of a modified Delphi. Canadian Pharmacists Journal. 2018;151:395-407.
14. Foley R.A., Hurard L.L., Cateau D., Koutaissoff D., Bugnon O., Niquille A. Physicians', nurses' and pharmacists' perceptions of determinants to deprescribing in nursing homes considering three levels of action: A qualitative study. Pharmacy. 2020;8:17.
15. Geijteman E.C.T., Huisman B.A.A., Dees M.K., Perez R., van der Rijt C.C.D., van Zuylen L., van der Heide A. Medication discontinuation at the end of life: A questionnaire study on physicians' experiences and opinions. Journal of Palliative Medicine. 2018;21:1166-1170.
16. Hand B.N., Krause J.S., Simpson K.N. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018;56:591-597.
17. Hansen C.R., Byrne S., O'Mahony D., Kearney P.M., Sahm L.J. Qualitative analysis of community pharmacists' opinions on their involvement in reducing potentially inappropriate prescribing. European Journal of Clinical Pharmacology. 2019;75:265-274.
18. Høghaug G., Skår R., Tran T.N., Schou-Bredal I. Nurses' experiences with newly acquired knowledge about medication management: A qualitative study. Journal of Nursing Management. 2019;27:1731-1737.
19. Holmqvist M., Thor J., Ros A., Johansson L. Evaluation of older persons' medications: A critical incident technique study exploring healthcare professionals' experiences and actions. BMC Health Services Research. 2021;21:557.
20. Huisman B.A.A., Geijteman E.C.T., Dees M.K., Schonewille N.N., Wieles M., van Zuylen L., Szadek K.M., van der Heide A. Role of nurses in medication management at the end of life: A qualitative interview study. BMC Palliative Care. 2020;19:68.
21. Kim J., Parish A.L. Polypharmacy and medication management in older adults. Nursing Clinics of North America. 2017;52:457-468.
22. Köberlein J., Gottschall M., Czarnecki K., Thomas A., Bergmann A., Voigt K. General practitioners' views on polypharmacy and its consequences for patient health care. BMC Family Practice. 2013;14:119.
23. Lincoln Y.S., Guba E.G. Naturalistic Inquiry. Sage Publications; Newbury Park, CA, USA: 1985.
24. Maier C.B. Nurse prescribing of medicines in 13 European countries. Human Resources for Health. 2019;17:95.
25. Mardani A., Griffiths P., Vaismoradi M. The role of the nurse in the management of medicines during transitional care: A systematic review. Journal of Multidisciplinary Healthcare. 2020;13:1347-1361.
26. Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G.E. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017;17:230.
27. McNeil M.J., Kamal A.H., Kutner J.S., Ritchie C.S., Abernethy A.P. The burden of polypharmacy in patients near the end of life. Journal of Pain and Symptom Management. 2016;51:178-183.
28. Midão L., Giardini A., Menditto E., Kardas P., Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Archives of Gerontology and Geriatrics. 2018;78:213-220.
29. Mohammed M.A., Moles R.J., Chen T.F. Medication-related burden and patients' lived experience with medicine: A systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6:e010035.
30. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2020;372:n71.
31. Pariseault C.A., Sharts-Hopko N., Blunt E. Nurse practitioners' experiences of polypharmacy in community-dwelling older adults. Journal of the American Association of Nurse Practitioners. 2020;33:811-817.
32. Pazan F., Wehling M. Polypharmacy in older adults: A narrative review of definitions, epidemiology and consequences. European Geriatric Medicine. 2021;12:443-452.
33. Rohde E., Domm E. Nurses' clinical reasoning practices that support safe medication administration: An integrative review of the literature. Journal of Clinical Nursing. 2018;27:e402-e411.
34. Rowe S., Pittman N., Balsom C., Druken R., Kelly D.V. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: A qualitative study. International Journal of Clinical Pharmacy. 2022;44:1370-1379.
35. Seto H., Ishimaru N., Ohnishi J., Kanzawa Y., Nakajima T., Shimokawa T., Imanaka Y., Kinami S. Multidisciplinary team deprescribing intervention for polypharmacy in elderly orthopedic inpatients: A propensity score-matched analysis of a retrospective cohort study. Internal Medicine. 2022;61:2417-2426.
36. Skirbekk H., Nortvedt P. Inadequate treatment for elderly patients: Professional norms and tight budgets could cause "ageism" in hospitals. Health Care Analysis. 2014;22:192-201.
37. Smith A., Macaden L., Kroll T., Alhusein N., Taylor A., Killick K., Stoddart K., Watson M. A qualitative exploration of the experiences of community dwelling older adults with sensory impairment/s receiving polypharmacy on their pharmaceutical care journey. Age and Ageing. 2019;48:895-902.
38. Spinewine A., Swine C., Dhillon S., Franklin B.D., Tulkens P.M., Wilmotte L., Lorant V. Appropriateness of use of medicines in elderly inpatients: Qualitative study. BMJ. 2005;331:935.
39. Sun W., Tahsin F., Barakat-Haddad C., Turner J.P., Haughian C.R., Abbass-Dick J. Exploration of home care nurse's experiences in deprescribing of medications: A qualitative descriptive study. BMJ Open. 2019;9:e025606.
40. Syyrilä T., Vehviläinen-Julkunen K., Härkänen M. Healthcare professionals' perceptions on medication communication challenges and solutions-text mining and manual content analysis-cross-sectional study. BMC Health Services Research. 2021;21:1226.
41. Thomas J., Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology. 2008;8:45.
42. Tong A., Flemming K., McInnes E., Oliver S., Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Medical Research Methodology. 2012;12:181.
43. Wilson E., Morbey H., Brown J., Payne S., Seale C., Seymour J. Administering anticipatory medications in end-of-life care: A qualitative study of nursing practice in the community and in nursing homes. Palliative Medicine. 2015;29:60-70.
44. Yang C., Lee D.T.F., Wang X., Chair S.Y. Effects of a nurse-led medication self-management intervention on medication adherence and health outcomes in older people with multimorbidity: A randomised controlled trial. International Journal of Nursing Studies. 2022;134:104314.
45. Young E.H., Pan S., Yap A.G., Reveles K.R., Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS ONE. 2021;16:e0255642.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
